title: Effects of omalizumab in a patient with three types of chronic urticaria.
authors.affiliation: Faculdade Evangélica de Medicina do Paraná, Paraná, Brazil; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Vieira Dos Santos
authors.forename: B
authors.initials: B
authors.lastname: Locks Bidese
authors.forename: J
authors.initials: J
authors.lastname: Rabello de Souza
authors.forename: M
authors.initials: M
authors.lastname: Maurer
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D000069444:Omalizumab; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab